Cargando…
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396712/ https://www.ncbi.nlm.nih.gov/pubmed/33440126 http://dx.doi.org/10.1080/14789450.2021.1876568 |
_version_ | 1783744436860092416 |
---|---|
author | Spencer, Chloe E Flint, Lucy E Duckett, Catherine J Cole, Laura M Cross, Neil Smith, David P Clench, Malcolm R |
author_facet | Spencer, Chloe E Flint, Lucy E Duckett, Catherine J Cole, Laura M Cross, Neil Smith, David P Clench, Malcolm R |
author_sort | Spencer, Chloe E |
collection | PubMed |
description | Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular behavior and is hence highly desirable in early-stage drug development. Analyzing the spatial distribution of drug compounds and endogenous molecules provides an insight into the efficacy of a drug whilst simultaneously giving information on biological responses. Areas Covered: In this review we will examine the main 3D cell culture systems employed and applications, which describe their integration with mass spectrometry imaging (MSI). Expert Opinion: MSI is a powerful technique that can map a vast range of molecules simultaneously in tissues without the addition of labels that can provide insights into the efficacy and safety of a new drug. The combination of MSI and 3D cell cultures has emerged as a promising tool in early-stage drug analysis. However, the most common administration route for pharmaceutical drugs is via oral delivery. The use of MSI in combination with models of the GI tract is an area that has been little explored to date, the reasons for this are discussed. |
format | Online Article Text |
id | pubmed-8396712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-83967122021-08-28 Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants Spencer, Chloe E Flint, Lucy E Duckett, Catherine J Cole, Laura M Cross, Neil Smith, David P Clench, Malcolm R Expert Rev Proteomics Review Introduction: Three-dimensional (3D) cell cultures have become increasingly important materials to investigate biological processes and drug efficacy and toxicity. The ability of 3D cultures to mimic the physiology of primary tissues and organs in the human body enables further insight into cellular behavior and is hence highly desirable in early-stage drug development. Analyzing the spatial distribution of drug compounds and endogenous molecules provides an insight into the efficacy of a drug whilst simultaneously giving information on biological responses. Areas Covered: In this review we will examine the main 3D cell culture systems employed and applications, which describe their integration with mass spectrometry imaging (MSI). Expert Opinion: MSI is a powerful technique that can map a vast range of molecules simultaneously in tissues without the addition of labels that can provide insights into the efficacy and safety of a new drug. The combination of MSI and 3D cell cultures has emerged as a promising tool in early-stage drug analysis. However, the most common administration route for pharmaceutical drugs is via oral delivery. The use of MSI in combination with models of the GI tract is an area that has been little explored to date, the reasons for this are discussed. Taylor & Francis 2021-02-02 /pmc/articles/PMC8396712/ /pubmed/33440126 http://dx.doi.org/10.1080/14789450.2021.1876568 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Spencer, Chloe E Flint, Lucy E Duckett, Catherine J Cole, Laura M Cross, Neil Smith, David P Clench, Malcolm R Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title_full | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title_fullStr | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title_full_unstemmed | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title_short | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants |
title_sort | role of maldi-msi in combination with 3d tissue models for early stage efficacy and safety testing of drugs and toxicants |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396712/ https://www.ncbi.nlm.nih.gov/pubmed/33440126 http://dx.doi.org/10.1080/14789450.2021.1876568 |
work_keys_str_mv | AT spencerchloee roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT flintlucye roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT duckettcatherinej roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT colelauram roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT crossneil roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT smithdavidp roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants AT clenchmalcolmr roleofmaldimsiincombinationwith3dtissuemodelsforearlystageefficacyandsafetytestingofdrugsandtoxicants |